CASI Pharmaceuticals Jumps 24% After Hours Despite Nasdaq Delisting
CASI shares rose over 24% in after-hours trading even as the company faces Nasdaq delisting and plans to shift trading to OTC Markets.
Beyond The Veil Editorial
Astrology Chart
Unknown, Unknown • Waxing Gibbous
Planetary Positions
Key Aspects
Tags
CASI Pharmaceuticals (NASDAQ: CASI) ripped more than 24% higher in after-hours trading—up to roughly $0.28—at the exact moment the company is staring down a formal Nasdaq delisting and signaling a move to OTC Markets. That’s not the “normal” script: delisting headlines typically crush liquidity expectations, not ignite a bid.
This kind of upside glitch is where mundane astrology gets useful: when the sky says “re-price it now” even while the fundamentals scream “structural damage.”
Veil Glimpse: When a market surges on bad news, you’re watching positioning and narrative control fight for dominance in real time.
Behind The Veil
Unlock the full decode
You're reading a premium decode. Subscribe to access the full analysis, forecast windows, and the complete archive.
- • Full decode library + archives
- • Premium predictions and timing windows
- • Veil Chat and Veil Agent access
The Veil (Free)
Start free access
Daily signals feed, map previews, and community-grade insights.
Behind The Veil
Go premium instantly
Full decode archives, premium predictions, and Veil Agent access.